Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus

Neuroscience

Volumn 95, Issue 1, 1999, Pages 119-126

  Chadha, A ^a   Dawson, L G ^a   Jenner, P G ^a   Duty, S ^a  

^a Hodgkin B   (United Kingdom)

Author keywords

Basal ganglia; GABA(A) receptor; mRNA; Nigrostriatal tract lesion; Rat

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; MESSENGER RNA; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLOBUS PALLIDUS; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; THALAMUS;

ANIMALS; AUTORADIOGRAPHY; BASAL GANGLIA; CORPUS STRIATUM; GENE EXPRESSION; MALE; MAZINDOL; NEURAL PATHWAYS; OXIDOPAMINE; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RNA, MESSENGER; SUBSTANTIA NIGRA; THALAMUS; TISSUE DISTRIBUTION;

EID: 0032702244     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00413-3     Document Type: Article

References (39)

1. Altschul S., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. molec. Biol. 215:1990;403-410.
2. Beckstead R.M., Domesick V.B., Nauta W.J. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175:1979;191-217.
3. A receptor subunit changes induced by unilateral 6-OHDA lesion of the nigrostriatal pathway. Molec. Brain Res. 48:1997;243-250.
4. A receptor subunit gene expression in the rodent basal ganglia and thalamus. Br. J. Pharmac. 126:1999;272P.
5. Chesselet M.F., Delfs J.M. Basal ganglia and movement disorders: an update. Trends Neurosci. 13:1996;277-280.
6. Duty S., Brotchie J.M. Enhancement of the behavioural response to apomorphine administration following repeated treatment in the 6-hydroxydopamine lesioned rat is temporally correlated with a rise in striatal preproenkephalin B but not preproenkephalin A gene expression. Expl Neurol. 144:1997;423-432.
7. A-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat. Prog. Brain Res. 99:1993;105-123.
8. A receptor subunit messenger RNAs by increased GABA concentrations in rat brain. Neuroscience. 71:1996;661-670.
9. Filion M., Tremblay L. Abnormal spontaneous activity of the globus pallidus neurons in monkeys with MPTP-induced Parkinsonism. Brain Res. 547:1991;142-151.
10. Fort P.L., Marty M., Piechaczyk S., El Sabrouty S., Dani C., Jeanteur P., Blanchard J.M. Various adult rat tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucl. Acids Res. 13:1985;1431-1441.
11. Gerfen C.G., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
12. Graham W.C., Crossman A.R., Woodruff G.N. Autoradiographic studies in animal models of hemi-Parkinsonism reveal D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathway in the rat. Brain Res. 514:1990;93-102.
13. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-253.
14. Griffiths P.D., Sambrook M.A., Perry R., Crossman A.R. Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease. J. neurol. Sci. 100:1990;131-136.
15. Groenewegen H.J., Berendse H.W., Wolters J.G., Lohman A.H.M. The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organisation. Prog. Brain Res. 85:1990;95-118.
16. Hefti F., Melamed E., Sahakian B.J., Wurtman R.J. Circling behaviour in rats with partial unilateral nigrostriatal lesions: effects of amphetamine, apomorphine and DOPA. Pharmac. Biochem. Behav. 12:1980;185-188.
17. A channel subtypes. Molec. Neurobiol. 18:1998;35-86.
18. 3H]mazindol autoradiography. J. Neurosci. 5:1985;1513-1521.
19. MacLeod N.K., James T.A., Kilpatrick I.C., Starr M.S. Evidence for a GABAergic nigrothalamic pathway in the rat. II. Electrophysiological studies. Expl Brain Res. 40:1980;55-61.
20. Marsden C.D. Parkinson's disease. J. Neurol. Neurosurg. Psychiat. 57:1994;672-681.
21. A receptor subtypes really occur in the brain? Trends Neurosci. 19:1996;139-143.
22. Mitchell I.J., Clarke C.E., Boyce S., Robertson R.G., Peggs D., Sambrook M.A., Crossman A.R. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroscience. 32:1989;213-226.
23. 2 subunit mRNAs following ischemic cortical lesions in rats. Brain Res. 816:1999;234-237.
24. A receptor changes in the substantia nigra of the rat following quinolinic acid lesions closely resemble Huntington's disease. Neuroscience. 66:1995;507-521.
25. A receptor subtype changes in the substantia nigra of the rat following quinolinate lesions in the striatum: a correlative in situ hybridization and immunohistochemical study. Neuroscience. 74:1996;89-98.
26. Pan H.S., Penney J.B., Young A.B. γ-Aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J. Neurochem. 45:1985;1396-1404.
27. Pan H.S., Waters J.R. Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat. Synapse. 2:1988;650-656.
28. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico- basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20:1995;91-127.
29. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, London.
30. Penney J.B., Young A.B. Quantitative autoradiography of neurotransmitter receptors in Huntington's disease. Neurology. 32:1982;1391-1395.
31. 3H]flunitrazepam autoradiography. Brain Res. 531:1990;95-104.
32. Robertson R.G., Graham W.C., Sambrook M.A., Crossman A.R. Further investigation into the pathophysiology of MPTP-induced Parkinsonism in the primate: an intracerebral microdialysis study of gamma-aminobutyric acid in the lateral segment of the globus pallidus. Brain Res. 563:1991;278-280.
33. Segovia J., Tossman U., Herrera-Marschitz M., Garcia-Munoz M., Ungerstedt U. Gamma-aminobutyric acid release in the globus pallidus in vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat. Neurosci. Lett. 70:1986;364-368.
34. A receptor subtypes. Pharmac. Rev. 47:1995;181-234.
35. A receptors on channel function. Neuron. 5:1990;703-711.
36. Soghomonian J.J., Laprade N. Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurones in the putamen of parkinsonian monkeys. Synapse. 27:1997;122-132.
37. Van der Kooy D., Carter D.A. The organisation of the efferent projections and striatal afferents of the entopeduncular nucleus and adjacent areas in the rat. Brain Res. 211:1981;15-36.
38. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12:1992;1040-1062.
39. Wooten G.F., Collins R.C. Metabolic effects of unilateral lesion of the substantia nigra. J. Neurosci. 1:1981;285-291.